Stellantis發佈新款標緻408 2023年登陸中國市場
格隆匯6月22日丨Stellantis(STLA.US)旗下法國品牌標緻在6月22日發佈了新款408車型,該公司相信這款新的溜背轎車將吸引那些對運動型多用途車(SUV)感到審美疲勞的消費者。近年來,suv在歐洲非常受歡迎,今年5月,suv在法國新銷量中所佔份額達到了創紀錄的46%,與傳統轎車持平。新款408將於明年初在歐洲推出,並在2023年中期登陸中國市場,屆時該車將在成都進行裝配。標緻最初將推出汽油和油電混合動力版本,隨後該公司還將推出純電動版本。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.